During the past decade, Five Towns Neuroscience Research conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 5 clinical trials were completed, i.e. on average, 166.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Five Towns Neuroscience Research" #1 sponsor was "JANSSEN Alzheimer Immunotherapy Research & Development, LLC" with 2 trials, followed by "Sunovion" with 2 trials sponsored, "Bial - Portela C S.A." with 1 trials sponsored, "Cephalon" with 1 trials sponsored and "Columbia University" with 1 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Five Towns Neuroscience Research" #1 collaborator was "Pfizer" with 2 trials as a collaborator, "National Institute of Neurological Disorders and Stroke (NINDS)" with 1 trials as a collaborator, "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator and "Sunovion" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Five Towns Neuroscience Research" are "Alzheimer's Disease" (3 trials), "Back Pain Lower Back Chronic" (1 trials), "Chronic Pain" (1 trials), "Drug Resistant Partial Onset Seizure" (1 trials) and "Epilepsy" (1 trials). Many other conditions were trialed in "Five Towns Neuroscience Research" in a lesser frequency.

Most popular intervention types in "Five Towns Neuroscience Research" are "Drug" (13 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "Bapineuzumab 0.5 mg/kg" (2 trials), "Bapineuzumab 1.0 m/kg" (2 trials), "Eslicarbazepine acetate" (2 trials) and "Placebo Control" (2 trials). Other intervention names were less common.

The vast majority of trials in "Five Towns Neuroscience Research" are 13 trials for "All" genders.

Currently, there are NaN active trials in "Five Towns Neuroscience Research". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Five Towns Neuroscience Research, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Five Towns Neuroscience Research, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".